SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cytrx Corp – ‘10-K’ for 12/31/13 – ‘R46’

On:  Tuesday, 3/4/14, at 6:18pm ET   ·   As of:  3/5/14   ·   For:  12/31/13   ·   Accession #:  799698-14-4   ·   File #:  0-15327

Previous ‘10-K’:  ‘10-K’ on 3/11/13 for 12/31/12   ·   Next:  ‘10-K’ on 3/10/15 for 12/31/14   ·   Latest:  ‘10-K’ on 3/27/24 for 12/31/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 3/05/14  Cytrx Corp                        10-K       12/31/13   77:9.7M

Annual Report   —   Form 10-K   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Form 10-K for Fiscal Year Ending 12/31/2013         HTML   1.30M 
 2: EX-4.8      Instrument Defining the Rights of Security Holders  HTML     46K 
 3: EX-10.22    Material Contract                                   HTML     68K 
 4: EX-10.23    Material Contract                                   HTML     53K 
 5: EX-10.24    Material Contract                                   HTML     53K 
 6: EX-10.25    Material Contract                                   HTML     52K 
 7: EX-10.29    Material Contract                                   HTML     24K 
 8: EX-10.30    Material Contract                                   HTML     24K 
 9: EX-10.31    Material Contract                                   HTML     24K 
10: EX-10.32    Material Contract                                   HTML     26K 
11: EX-23.1     Consent of Experts or Counsel                       HTML     22K 
12: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
13: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
14: EX-32.1     Certification -- §906 - SOA'02                      HTML     22K 
15: EX-32.2     Certification -- §906 - SOA'02                      HTML     22K 
54: R1          Document and Entity Information                     HTML     49K 
44: R2          Consolidated Balance Sheets                         HTML     95K 
52: R3          Consolidated Balance Sheets (Parenthetical)         HTML     48K 
56: R4          Consolidated Statements of Operations               HTML     70K 
72: R5          Consolidated Statements of Stockholders' Equity     HTML     71K 
46: R6          Consolidated Statements of Cash Flows               HTML    116K 
51: R7          Nature of Business                                  HTML     28K 
41: R8          Summary of Significant Accounting Policies          HTML     71K 
33: R9          Receivables                                         HTML     26K 
73: R10         Prepaid and Other Assets                            HTML     23K 
58: R11         Short-term Investments                              HTML     27K 
57: R12         Equipment and Furnishings                           HTML     31K 
62: R13         Accrued Expenses and Other Current Liabilities      HTML     31K 
63: R14         Warrant Liabilities                                 HTML     36K 
61: R15         Commitments and Contingencies                       HTML     51K 
64: R16         Equity Transactions                                 HTML     33K 
53: R17         Investments in ADVENTRX Pharmaceuticals             HTML     26K 
55: R18         Stock Options and Warrants                          HTML    221K 
60: R19         Sale of Assets                                      HTML     23K 
77: R20         Stockholder Protection Rights Plan                  HTML     25K 
67: R21         Income Taxes                                        HTML     58K 
48: R22         Quarterly Financial Data (Unaudited)                HTML     48K 
59: R23         Subsequent Events                                   HTML     59K 
50: R24         Schedule Ii - Valuation and Qualifying Accounts     HTML     40K 
27: R25         Summary of Significant Accounting Policies          HTML    124K 
                (Policies)                                                       
68: R26         Summary of Significant Accounting Policies          HTML     47K 
                (Tables)                                                         
74: R27         Equipment and Furnishings (Tables)                  HTML     29K 
37: R28         Accrued Expenses and Other Current Liabilities      HTML     30K 
                (Tables)                                                         
36: R29         Warrant Liabilities (Tables)                        HTML     34K 
39: R30         Commitments and Contingencies (Tables)              HTML     45K 
40: R31         Stock Options and Warrants (Tables)                 HTML    218K 
42: R32         Income Taxes (Tables)                               HTML     53K 
26: R33         Quarterly Financial Data (Unaudited) (Tables)       HTML     46K 
65: R34         Subsequent Events (Tables)                          HTML     58K 
47: R35         Nature of Business (Details)                        HTML     40K 
49: R36         Summary of Significant Accounting Policies          HTML     67K 
                (Details)                                                        
30: R37         Receivables (Details)                               HTML     23K 
76: R38         Prepaid and Other Assets (Details)                  HTML     23K 
22: R39         Short-term Investments (Details)                    HTML     26K 
43: R40         Equipment and Furnishings (Details)                 HTML     34K 
71: R41         Accrued Expenses and Other Current Liabilities      HTML     35K 
                (Details)                                                        
29: R42         Warrant Liabilities (Details)                       HTML     41K 
35: R43         Commitments and Contingencies (Details)             HTML     83K 
38: R44         Equity Transactions (Details)                       HTML     49K 
45: R45         Investments in ADVENTRX Pharmaceuticals (Details)   HTML     32K 
25: R46         Stock Options and Warrants (Details)                HTML    304K 
32: R47         Sale of Assets (Details)                            HTML     24K 
23: R48         Stockholder Protection Rights Plan (Details)        HTML     33K 
70: R49         Income Taxes (Details)                              HTML     96K 
28: R50         Quarterly Financial Data (Unaudited) (Details)      HTML     37K 
66: R51         Subsequent Events (Details)                         HTML     87K 
31: R52         Schedule Ii - Valuation and Qualifying Accounts     HTML     32K 
                (Details)                                                        
75: XML         IDEA XML File -- Filing Summary                      XML    100K 
24: EXCEL       IDEA Workbook of Financial Reports                  XLSX    171K 
34: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS   1.26M 
16: EX-101.INS  XBRL Instance -- cytr-20131231                       XML   1.91M 
18: EX-101.CAL  XBRL Calculations -- cytr-20131231_cal               XML    190K 
19: EX-101.DEF  XBRL Definitions -- cytr-20131231_def                XML    469K 
20: EX-101.LAB  XBRL Labels -- cytr-20131231_lab                     XML   1.57M 
21: EX-101.PRE  XBRL Presentations -- cytr-20131231_pre              XML    873K 
17: EX-101.SCH  XBRL Schema -- cytr-20131231                         XSD    162K 
69: ZIP         XBRL Zipped Folder -- 0000799698-14-000004-xbrl      Zip    166K 


‘R46’   —   Stock Options and Warrants (Details)


This is an IDEA Financial Report.  [ Alternative Formats ]



 
v2.4.0.8
Stock Options and Warrants (Details) (USD $)
12 Months Ended 12 Months Ended 12 Months Ended 6 Months Ended
Employees [Member]
Employees [Member]
Employees [Member]
Employees [Member]
Maximum [Member]
Non-employees [Member]
Non-employees [Member]
Non-employees [Member]
Senior management [Member]
Senior management [Member]
Senior management [Member]
Employees and Directors [Member]
Directors [Member]
Directors [Member]
Directors [Member]
Stock Options [Member]
Stock Options [Member]
Range $ 1.83 - 2.50 [Member]
Stock Options [Member]
Range $ 2.51 - 3.50 [Member]
Stock Options [Member]
Range $ 3.51 - 8.00 [Member]
Stock Options [Member]
Range $ 8.01 - 32.55 [Member]
Stock Options [Member]
Employees [Member]
Stock Options [Member]
Employees [Member]
Stock Options [Member]
Employees [Member]
Stock Options [Member]
Employees [Member]
Minimum [Member]
Stock Options [Member]
Employees [Member]
Minimum [Member]
Stock Options [Member]
Employees [Member]
Minimum [Member]
Stock Options [Member]
Employees [Member]
Maximum [Member]
Stock Options [Member]
Employees [Member]
Maximum [Member]
Stock Options [Member]
Employees [Member]
Maximum [Member]
Stock Options [Member]
Non-employees [Member]
Stock Options [Member]
Non-employees [Member]
Stock Options [Member]
Non-employees [Member]
Stock Options [Member]
Employees and Directors [Member]
Stock Options [Member]
Employees and Directors [Member]
Stock Options [Member]
Employees and Directors [Member]
Warrants [Member]
Warrants [Member]
Warrants [Member]
Warrants [Member]
Range $ 1.82 - 2.50 [Member]
Warrants [Member]
Range $ 2.51 - 5.50 [Member]
Warrants [Member]
Range $ 5.51 - 11.50 [Member]
Warrants [Member]
Range $ 11.51 - 24.50 [Member]
Restricted Stock [Member]
Restricted Stock [Member]
Senior management [Member]
2000 Long Term Incentive Plan [Member]
2008 Stock Incentive Plan [Member]
2008 Stock Incentive Plan [Member]
Restricted Stock [Member]
Senior management [Member]
2008 Stock Incentive Plan [Member]
Restricted Stock [Member]
Senior management [Member]
2008 Stock Incentive Plan [Member]
Restricted Stock [Member]
Senior management [Member]
2008 Stock Incentive Plan [Member]
Restricted Stock [Member]
Senior management [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                                                                                              
Common stock reserved for future issuance (in shares)                                                                                                   1,400,000 10,000,000        
Share-based compensation, shares subject to stock options (in shares) 4,400,000                                                                                                 800,000 5,600,000        
Reverse stock split conversation ratio 1-for-7                                                                                                            
Common stock reserved after reverse spilt for future issuance (in shares)                                                                                                     5,000,000        
Expiration date                                                                                                   Aug. 06, 2010          
Share-based compensation, shares available for future grant (in shares)                                                                                                   0 4,400,000        
Share-based compensation arrangement by share-based payment award, fair value assumptions and methodology [Abstract]                                                                                                              
Share based compensation arrangement by share-based payment award fair value assumptions method used                                                   Black-Scholes option-pricing model,                 Black-Scholes option-pricing model                                        
Risk-free interest rate (in hundredths)                                                       1.23% 0.91% 0.83%   2.79% 1.78%   2.05% 0.00% 2.77%                                    
Expected volatility (in hundredths)                                                       89.00% 85.00% 0.00%   89.00% 82.00%   84.80% 0.00% 70.00%                                    
Expected lives (years)                   10 years                                     6 years 6 years 6 years 10 years 10 years 10 years 10 years 0 years 10 years                                    
Expected dividend yield (in hundredths)                                                   0.00% 0.00% 0.00%             0.00% 0.00% 0.00%                                    
Vesting period 3 years                                                                                                            
Estimated annualized forfeiture rate (in hundredths)             12.00% 12.00% 13.00%         2.00% 2.00% 2.00%   0.00% 0.00% 0.00%                                                                      
Unrecognized compensation expense related to unvested stock options, granted                     $ 0           $ 4,300,000                                                                            
Unrecognized compensation cost, recognized as expense over a weighted-average period 1 year 4 months 10 days                                                                                                            
Number of Options (Employees and Non-Employees) [Abstract]                                                                                                              
Outstanding - beginning of year (in shares)                                                                     142,143 143,572 142,143 3,240,850 1,763,923 1,268,209 7,518,113 7,397,415 1,294,639                        
Granted (in shares)                                                                     25,000 0 1,429 3,323,176 1,541,002 499,286 816,667 285,716 6,440,000           100,000            
Exercised (in shares)                                                                     0 (1,429) 0 (476) (1,071) 0 (8,572) (5,714) 0                        
Forfeited (in shares)                                                                     0 0 0 (127,812) (63,004) (3,572) 0 (28,571) 0                        
Expired (in shares)                                                                     0 0 0 (207,145) 0 0 (1,599) (130,733) (337,224)                        
Outstanding - end of year (in shares)                                                                     167,143 142,143 143,572 6,228,593 3,240,850 1,763,923 8,324,609 7,518,113 7,397,415                        
Exercisable at end of year (in shares)                                                                     167,143 133,215 125,714 3,125,720 1,918,461 1,070,419 7,924,609 7,452,396 7,396,701                        
Weighted average fair value of stock options granted during the year (in dollars per share)                                                                     $ 1.98 $ 0 $ 2.94 $ 1.82 $ 1.44 $ 1.75 $ 1.31 $ 1.22 $ 2.42                        
Weighted-Average Exercise Price Options [Abstract]                                                                                                              
Outstanding - beginning of year (in dollars per share)                                                                     $ 6.20 $ 6.17 $ 6.30 $ 4.08 $ 6.01 $ 7.49 $ 5.09 $ 5.32 $ 10.29                        
Granted (in dollars per share)                                                                     $ 2.79 $ 0 $ 2.94 $ 2.43 $ 1.86 $ 2.38 $ 2.80 $ 2.06 $ 4.48                        
Exercised (in dollars per share)                                                                     $ 0 $ 2.94 $ 0 $ 1.93 $ 2.80 $ 0 $ 4.48 $ 1.89 $ 5.32                        
Forfeited (in dollars per share)                                                                     $ 0 $ 0 $ 0 $ 3.09 $ 3.89 $ 6.93 $ 0 $ 1.89 $ 0                        
Expired (in dollars per share)                                                                     $ 0 $ 0 $ 0 $ 9.59 $ 0 $ 0 $ 14.99 $ 11.90 $ 8.68                        
Outstanding - end of year (in dollars per share)                                                                     $ 5.69 $ 6.20 $ 6.17 $ 3.11 $ 4.08 $ 6.01 $ 4.86 $ 5.09 $ 5.32                        
Exercisable at end of year (in dollars per share)                                                                     $ 5.69 $ 6.10 $ 5.95 $ 3.86 $ 3.69 $ 7.49 $ 4.98 $ 5.11 $ 5.31                        
Number of Unvested Stock Options (Employees and Non-Employees) [Abstract]                                                                                                              
Non-vested at beginning of period (in shares)                                                   1,322,389 693,504 453,645             8,929 17,857 41,066                                    
Granted (in shares)                                                   3,323,176 1,541,002 499,286             25,000 0 1,429                     100,000              
Vested (in shares)                                                   (1,450,404) (849,113) (255,855)             (33,929) (8,928) (24,638)                             50,000 50,000    
Pre-vested forfeitures (in shares)                                                   (92,288) (63,004) (3,572)             0 0 0                                    
Non-vested at end of period (in shares)                                                   3,102,873 1,322,389 693,504             0 8,929 17,857                                    
Weighted-Average Grant Date Fair Value per Share [Abstract]                                                                                                              
Non-vested at beginning of period (in dollars per share)                                                   $ 1.57 $ 2.81 $ 5.25             $ 19.95 $ 19.95 $ 13.86                                    
Granted (in dollars per share)                                                   $ 1.82 $ 1.44 $ 1.75             $ 1.98 $ 0 $ 0.81                                    
Vested (in dollars per share)                                                   $ 2.46 $ 3.69 $ 4.90             $ 6.71 $ 19.95 $ 8.61                                    
Pre-vested forfeitures (in dollars per share)                                                   $ 2.15 $ 2.97 $ 6.93             $ 0 $ 0 $ 0                                    
Non-vested at end of period (in dollars per share)                                                   $ 1.66 $ 1.57 $ 2.81             $ 0 $ 19.95 $ 19.95                                    
Value of restricted shares issued                                                                                                           627,000 186,900
Issuance of stock options to certain consultants in exchange for services                     40,000 0 31,000                                                                                    
Expected to vest (in shares)                                                                                               50,000              
Expected to vest over subsequent period (in shares)                                                                                               50,000              
Share based compensation, shares authorized under significant ranges of outstanding stock option plans in period [Abstract]                                                                                                              
Range of Exercise Prices, Lower Range (in dollars per share)                                           $ 1.83 $ 2.51 $ 3.51 $ 8.01                                     $ 1.82 $ 2.51 $ 5.51 $ 11.51                
Range of Exercise Prices, Upper Range (in dollars per share)                                           $ 2.50 $ 3.50 $ 8.00 $ 32.55                                     $ 2.50 $ 5.50 $ 11.50 $ 24.50                
Number of Options (in shares)                                         6,395,736 5,130,056 194,482 692,701 378,497                               8,324,609     860,003 6,805,285 23,172 636,149                
Weighted-Average Remaining Contractual Life                                         8 years 7 months 2 days 9 years 5 months 12 days 6 years 11 months 5 days 5 years 8 months 8 days 3 years 1 month 17 days                               2 years 6 months     3 years 3 months 4 days 2 years 6 months 25 days 0 years 0 months 14 days 0 years 9 months 25 days                
Weighted-Average Exercise Price (in dollars per share)                                         $ 3.11 $ 2.21 $ 2.79 $ 6.67 $ 8.86                               $ 4.86     $ 2.29 $ 4.43 $ 6.12 $ 12.89                
Number of Options Exercisable (in shares)                                         3,292,863 2,102,373 151,625 660,368 378,497                               7,924,609     460,003 6,805,285 23,172 636,149                
Weighted-Average Contractual Life                                         8 years 7 months 2 days 9 years 5 months 12 days 6 years 11 months 5 days 5 years 8 months 8 days 3 years 1 month 17 days                                                            
Weighted-Average Exercise Price, Options Exercisable (in dollars per share)                                         $ 3.86 $ 2.14 $ 2.69 $ 6.75 $ 8.86                               $ 4.98     $ 2.11 $ 4.43 $ 6.12 $ 12.89                
The aggregate intrinsic value of outstanding options                                         13,000,000                                                                    
Aggregate intrinsic value of options exercised                                         0                                                                    
Aggregate intrinsic value of options vested                                         $ 5,800,000                                                                    
Closing price of the common stock (in dollars per share)   $ 2.25   $ 2.50   $ 3.57                             $ 6.27                                                                    
Shares underlying warrants (in shares) 6,984,716   6,984,716   7,115,447                                                                                                    

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
12/31/1410-K,  8-K
6/30/1410-Q
Filed as of:3/5/148-K
Filed on:3/4/148-K
For Period end:12/31/13
10/15/13
12/31/1210-K,  4,  4/A,  8-K
10/23/124
12/31/1110-K
8/1/118-K
8/6/10
 List all Filings 
Top
Filing Submission 0000799698-14-000004   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 3:30:05.2am ET